跳至主要内容
临床试验/IRCT20171120037376N1
IRCT20171120037376N1招募中2 期

A clinical trial to compare the effectiveness of spironolactone with the standard treatment in right ventricular function in group 1 pulmonary hypertension patients

Vice Chancellor for Research, Mashhad University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
12 years 至 76 years(—)
性别
All

入选标准

  • Patients with group 1 pulmonary hypertension; aged between 12 and 76 years.
  • Exclusion criteria: Eisenmenger's syndrome; congenital diseases; scleroderma, thalassemia, systemic disease, cirrhosis, cor pulmonale, renal failure; frequent readmission and receiving inotropic therapy; left systolic dysfunction; mental disabilities; pulmonary disease of asthma; and unwillingness to follow up.

排除标准

  • 未提供

研究者

发起方
Vice Chancellor for Research, Mashhad University of Medical Sciences

相似试验